Navigation Links
Frost & Sullivan Recognizes DSM Biomedical's Outstanding Growth as a 'Total Solutions' Provider in the Medical Device Coatings Market
Date:9/8/2014

MOUNTAIN VIEW, Calif., Sept. 8, 2014 /PRNewswire/ -- Based on its recent analysis of the medical device coatings market, Frost & Sullivan recognizes DSM Biomedical with the 2014 North America Frost & Sullivan Award for Growth Excellence Leadership. DSM Biomedical is a total solutions provider that works with customers from start to finish in the medical device development process. The company has stood out for its innovation-centric growth policies, close relationships with value chain participants, and stellar customer experience.

DSM Biomedical has successfully diversified and sustained growth by not only competing as a coating formulator, but also positioning itself as a coating applicator. A part of this process is that it collaborates with customers to set up coating application equipment at their facilities. Through its strong brand recognition and customizable product offering, DSM Biomedical outperforms competitors in the total customer experience.

DSM Biomedical's new coating service plant addresses customers' coating concerns and enables them to focus on their core competencies. This value addition gives it an advantage over other companies when dealing with device-makers that make their own coatings. It also allows them to scale the production process in order to succeed in a low-cost manufacturing setting.

Its adjacent industrial coating business has provided it with expertise in coating development and application, which helped boost growth in diverse applications. For example, its VitroStealth® antifouling hydrophilic coating is used on medical devices as well as on glucose monitoring biosensors.

In a space marked by intense competition, DSM Biomedical's top-line growth has consistently been positioned above the industry average of 7 percent to 10 percent. Although other companies have maintained a similar pace of growth, DSM Biomedical has achieved this success within a short span of seven years.

"The company's strong growth can be attributed to its strength in hydrophilic and antimicrobial coatings, multifunctional coating portfolio and experience in working with device-makers in developing coating application methods," said Frost & Sullivan Research Analyst Reuben Sequeira. "Additionally, its brand awareness and skill in industrial coatings and other bio-based products and services have added thrust to its growth."

The company stays abreast of new market trends and unmet needs through market surveillance evaluations after product launches, regular detailed questionnaires, and direct interactions with the FDA, surgeons, and patients. Furthermore, its proficiency in bio-based materials allows it to efficiently evaluate medical device-makers' coating needs.

DSM Biomedical also grows inorganically, as is evident from its acquisition of Kensey Nash, a company that develops regenerative medicine utilizing proprietary collagen and synthetic polymer technology.

"Frost & Sullivan expects DSM Biomedical to sustain its growth by strengthening capabilities through key mergers, acquisitions, partnerships and collaborations," noted Sequeira. "The company's global reach and a history of Master Files to speed products to market are helping it become the materials collaborator of choice."

"We are honored to be awarded the Frost & Sullivan Award for Growth Excellence Leadership," said Dr. Hinke Malda, Global Director Medical Coatings at DSM Biomedical. "DSM is committed to continued excellence and innovation in the medical device coatings market."

Its cross-functional knowhow and strategy of value-added partnerships and acquisitions have ensured DSM Biomedical's highly competitive participation in the medical device coatings market.

Each year, Frost & Sullivan presents this award to the company that demonstrates excellence in growth and customer value. It recognizes the superiority of the product/service as well as the overall customer, purchase, ownership and service experience offered, which has resulted in the recipient company seeing above-market growth and increased share of wallet. The award lauds the growth, diversification and sustainability strategies of the company.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

DSM – Bright Science. Brighter Living.™
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 24,500 employees deliver annual net sales of around €10 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Contact:

Mireya Espinoza
P: 210.247.3870
F: 210.348.1003
E: mireya.espinoza@frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing
2. Biocompatible Protective Coatings Widen Application Scope in Medical Devices, Finds Frost & Sullivan
3. Frost & Sullivan Recognizes BioMarker Strategies for its Ground-Breaking Innovation in Solid Tumor Diagnostics
4. Bright Future Ahead for Biopharmaceutical Contract Manufacturing, Says Frost & Sullivan
5. Frost & Sullivan Presents bitop AG with the 2013 New Product Innovation Award in the Extremolytes Therapeutics Market
6. Frost & Sullivan Recognizes Sciformixs Continued Growth in the Increasingly Complex Pharmaceutical KPO Market
7. Oxitec Recognised by Prestigious Frost and Sullivan Award for its Pioneering System of Pest Control
8. Frost & Sullivan: Modest Growth Projected in the U.S. Breast Imaging Systems Market Amidst Increasing Breast Cancer Prevalence
9. Frost & Sullivan Recognizes A*STAR, Singapore with the 2012 Asia Pacific National Innovation Development Award
10. Accountable Care and Value-Based Purchasing Drives Adoption of Advanced Solutions for Health Data Analytics, Finds Frost & Sullivan
11. Rosetta Genomics Receives 2012 North American Entrepreneurial Company of the Year Award by Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2018)... ... 2018 , ... Each year Forbes receives thousands of nominations for candidates wishing ... by individuals under 30 years of age. The Forbes 30 Under 30 list showcases ... to Venture Capital and Science. , In 2017, Visikol CEO Dr. Michael Johnson ...
(Date:11/13/2018)... ... 13, 2018 , ... Renowned Honolulu veterinarian, Dr. Patrick Leadbeater, has begun offering ... Dr. Leadbeater, of Kahala Pet Hospital on Oahu, is a skilled surgeon ... to the island of Kauai on an almost weekly basis to perform surgery at ...
(Date:11/13/2018)... ... 2018 , ... Aditya Humad, Managing Partner of KICVentures ... it is still trending upward with growing valuations based on a largely under-served ... pricing pressure and increased competition as reasons often cited by institutional investors to ...
(Date:11/11/2018)... ... November 09, 2018 , ... Triple W, an innovator of connected health ... Honoree for DFree ®, the first health tech wearable device for incontinence ... go to the bathroom. The announcement was made during CES Unveiled New York, an ...
Breaking Biology Technology:
(Date:11/29/2018)... ... November 29, 2018 , ... ... to collaborate with the new NSF Engineering Research Center for Cell Manufacturing ... brought together to develop transformative tools and technologies for the consistent, scalable and ...
(Date:11/27/2018)... , ... November 27, 2018 , ... ... cryogenics industry a sealing solution with a broader range of usage temperature compared ... PEEK expert will introduce its new VICTREX CTâ„¢ 200 for dynamic sealing applications ...
(Date:11/20/2018)... , ... November 19, 2018 , ... ... Applications (academic research tools, drug development, agriculture, human clinical therapeutics, and animal and ... products), by Technology (drug compound and target screening, and agriculture and industrial use), ...
Breaking Biology News(10 mins):